TrialMedicine2020

Consolidation period of 18 months no better at promoting off-treatment durability in HBeAg-positive chronic hepatitis B patients with tenofovir disoproxil fumarate treatment than a 12-month period: A prospective randomized cohort study.

Chun-Hsiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.